Novavax (NASDAQ:NVAX – Get Free Report) issued its quarterly earnings data on Tuesday. The biopharmaceutical company reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of ($1.43) by $2.01, Briefing.com reports. The business had revenue of $424.40 million during the quarter, compared to the consensus estimate of $264.16 million. Novavax’s quarterly revenue […]
Novavax, Inc. (NASDAQ:NVAX – Get Free Report) was the target of unusually large options trading on Tuesday. Stock traders bought 18,494 call options on the stock. This represents an increase of 26% compared to the average daily volume of 14,684 call options. Hedge Funds Weigh In On Novavax A number of large investors have recently […]
Shares of Novavax, Inc. (NASDAQ:NVAX – Get Free Report) have been given a consensus rating of “Hold” by the six ratings firms that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and two have assigned a buy recommendation […]
Novavax, Inc. (NASDAQ:NVAX – Get Free Report) has been assigned an average recommendation of “Hold” from the six brokerages that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating on the company. […]
StockNews.com upgraded shares of Novavax (NASDAQ:NVAX – Free Report) from a sell rating to a hold rating in a research report released on Thursday. Other equities analysts have also recently issued research reports about the company. HC Wainwright dropped their target price on Novavax from $110.00 to $35.00 in a research report on Wednesday, May […]